Free Trial

Sutro Biopharma (STRO) SEC Filings & 10K Form

Sutro Biopharma logo
$1.99 +0.09 (+4.74%)
Closing price 02/4/2025 04:00 PM Eastern
Extended Trading
$2.00 +0.01 (+0.25%)
As of 08:39 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Sutro Biopharma SEC Filings

DateFilerForm TypeView
12/10/2024
7:00 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:54 PM
Point72 Asset Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:30 PM
Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/12/2024
8:34 AM
Adage Capital Management, L.P. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
11/04/2024
1:09 PM
Sutro Biopharma (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
08/13/2024
3:31 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/13/2024
3:16 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:38 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/12/2024
3:40 PM
Jagpal Sukhi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2024
3:10 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/10/2024
3:11 PM
Leyman Barbara (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:29 PM
Petree Daniel H (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:30 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
3:31 PM
Sutro Biopharma (Issuer)
Wigginton Jon Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:19 PM
Dybbs Michael (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:21 PM
Freund John Gordon (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:22 PM
Hunter Heidi (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
3:24 PM
Lobacki Joseph M (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2024
3:34 PM
Sutro Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/12/2024
4:59 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2024
4:10 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2024
3:58 PM
Sutro Biopharma (Filer)
Form 424B5
04/02/2024
5:04 AM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
3:30 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/22/2024
3:28 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4/A
03/07/2024
6:12 PM
FITZPATRICK LINDA A (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:26 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:28 PM
Gerber Hans-Peter (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:31 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
3:32 PM
Srinivasan Venkatesh (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:18 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
3:21 PM
Chung Jane (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:40 PM
NEWELL WILLIAM J (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
3:29 PM
ALBINI EDWARD C (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
3:15 PM
Borgman Anne Elizabeth (Reporting)
Sutro Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2024
3:33 PM
Sutro Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2024
11:16 AM
Sutro Biopharma (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
02/12/2024
5:06 AM
Rubric Capital Management LP (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
02/09/2024
3:27 PM
Sutro Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/07/2024
6:56 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Sutro Biopharma (Subject)
Form SC 13G/A
Your chance to get on the next “60-Second Trade” (Ad)

Even retirees are being forced back to work just to keep up. And if you're waiting for help from the Fed or government... Well, you might be waiting a very long time. But Roger Scott has uncovered something interesting... What if there was a way to fight back against inflation? A simple method you could use right from your phone...

Roger wants to share the complete details with you here.
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:STRO) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners